Literature DB >> 4085977

Prognostic significance of DNA-analysis by flow cytometry in non-Hodgkin's lymphoma.

G Roos, U Dige, P Lenner, J Lindh, H Johansson.   

Abstract

DNA analysis by flow cytometry was performed on lymph node cells obtained from 65 untreated patients with non-Hodgkin's lymphoma. According to the Kiel classification 41 cases were of low grade malignancy and 24 cases belonged to the high grade malignancy group. 47 out of 61 evaluable cases were diploid/near-diploid, 12 were aneuploid and 2 cases showed polyploidy. No difference in survival was found between diploid/near-diploid and aneuploid cases. The percentage of S-phase cells was found to be a valuable prognostic parameter. Using a cut point at 4 per cent S-phase cells between low and high S-phase lymphomas a highly significant difference in survival was demonstrated (p = 0.0004). The actuarial survival up to 3 years was about 77 per cent for lymphomas with less than 4 per cent S-phase cells to be compared with 20 per cent for patients with high S-phase (greater than or equal to 4 per cent) lymphomas. Subdivision according to the percentage of S-phase cells seemed to be a better prognostic predictor than morphologic subclassification.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4085977     DOI: 10.1002/hon.2900030403

Source DB:  PubMed          Journal:  Hematol Oncol        ISSN: 0278-0232            Impact factor:   5.271


  11 in total

Review 1.  Review: assessment of cell proliferation in histological material.

Authors:  P A Hall; D A Levison
Journal:  J Clin Pathol       Date:  1990-03       Impact factor: 3.411

2.  Hodgkin's disease: a flow cytometric study.

Authors:  K G Morgan; P Quirke; C J O'Brien; C C Bird
Journal:  J Clin Pathol       Date:  1988-04       Impact factor: 3.411

3.  Cell proliferation in non-Hodgkin's lymphomas. Digital image analysis of Ki-67 antibody staining.

Authors:  B R Schwartz; G Pinkus; S Bacus; M Toder; D S Weinberg
Journal:  Am J Pathol       Date:  1989-02       Impact factor: 4.307

4.  Prognostic indicators in centroblastic-centrocytic lymphoma.

Authors:  N R Griffin; M R Howard; P Quirke; C J O'Brien; J A Child; C C Bird
Journal:  J Clin Pathol       Date:  1988-08       Impact factor: 3.411

5.  Nuclear DNA content of non-endemic Burkitt's lymphoma.

Authors:  T Lehtinen; M Lehtinen; R Aine; O P Kallioniemi; T Leino; T Hakala; P Leinikki; M Alavaikko
Journal:  J Clin Pathol       Date:  1987-10       Impact factor: 3.411

6.  DNA content of T-cell lymphomas. A flow-cytometric analysis.

Authors:  D A Egerter; J W Said; S Epling; S Lee
Journal:  Am J Pathol       Date:  1988-02       Impact factor: 4.307

Review 7.  Prognostic factors in the non-Hodgkin's lymphomas--a time for consensus?

Authors:  J A Child
Journal:  Br J Cancer       Date:  1991-06       Impact factor: 7.640

8.  DNA content and prognosis of non-Hodgkin's lymphoma.

Authors:  D R Morgan; J M Williamson; P Quirke; A D Clayden; M E Smith; C J O'Brien; D L Allison; J A Child; C C Bird
Journal:  Br J Cancer       Date:  1986-10       Impact factor: 7.640

9.  Contribution of 3H-thymidine labelling index and flow cytometric S-phase in predicting survival of patients with non-Hodgkin's lymphoma.

Authors:  A Costa; R Silvestrini; R Giardini; G Messina-Gabrielli; P Boracchi; S Veneroni
Journal:  Br J Cancer       Date:  1992-10       Impact factor: 7.640

10.  Mitotic activity in non-Hodgkin's lymphoma. Relation to the Kiel classification and to prognosis.

Authors:  M Akerman; L Brandt; A Johnson; H Olsson
Journal:  Br J Cancer       Date:  1987-02       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.